An SGLT-2 inhibitor reduces liver fat and ALT levels in people who have type 2 diabetes.Read More »
Monthly Archives: August 2018
Elevated eGR fund to possibly lead to renal damage.Read More »
Even as 2nd-line drugs, sulfonylureas shown to be cardiotoxic with high rate of low blood glucoseRead More »
Patients who have normoglycemia still at risk for glucose spikes and diabetes.Read More »
Study investigates preservation or improvement of B-cell function using metformin with or without short-term insulin.Read More »
Guest Post by David Kliff, Editor, Diabetic Investor
This weekend, the most dedicated people in diabetes will gather in Baltimore for the AADE conference. Year after year, these amazing people gather to see all the latest toys in the toy chest, learn about all the new drugs, and share insights into how they are impacting the lives of the patients they work with.
Would you be more open to prescribing a GLP-1 Inhibitor if there was an oral product rather than an injectable? Follow the link to share your opinion and see what your colleagues think.Read More »
According to a recent study, frequently consuming meat, poultry, or fish cooked at high temperatures increases the risk for hypertension by how much?
Follow the link for the answer.Read More »
Little or no excess risk of death, MI, stroke for those with five risk-factor variables within target rangesRead More »
Gene variants do not modify the associations of 25(OH)D with lipidsRead More »